CERT - Certara, Inc. Stock Analysis | ConvictionStocks
Healthcare
Certara, Inc.
CERT
$8.00+5.96%
Price is delayed.
Add to watchlist
About Certara, Inc.
Certara provides software that helps pharmaceutical and biotech companies develop and bring drugs to market more efficiently. The company's tools simulate how drugs behave in the body, predict whether a drug will work, and help organize the massive amounts of data needed to get regulatory approval from agencies like the FDA. They also offer software for managing the paperwork and submissions required to sell drugs in different countries. Certara serves drug makers in all stages, from early research through getting a medicine approved and to market.
1D1W1M3M1Y5YMAX
Loading chart...
Chart powered by TradingView Lightweight Charts
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
What each number means, in plain English, with the Wall Street name where the two differ.
A plain-English summary of the company.
How many analysts cover it, and the count behind each rating.